Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21

Trial Status

Completed1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT02533765Phase 2Completed
Olaparib as Salvage Treatment for Cisplatin-resistant Germ Cell Tumor
Neoplasms, Germ Cell and Embryonal
PrincipalinvestigatorStart date: 2015-09-11

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Istituto Nazionale Tumori di Napoli

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Lawrence Einhorn, MD

Indiana Univeristy School of Medicine

Moderately Similar
1 trials

Shared therapeutic areas:

Neoplasms, Germ Cell and Embryonal
Similarity Score30%

Gustavo Werutsky, MD

Latin American Cooperative Oncology Group

Moderately Similar
9 trials

Shared therapeutic areas:

Neoplasms, Germ Cell and Embryonal
Similarity Score30%

Kyunggi Cho, MD,PhD

CHA University

Moderately Similar
1 trials

Shared therapeutic areas:

Neoplasms, Germ Cell and Embryonal
Similarity Score30%

Christophe Massard, MD

Gustave Roussy Cancer Campus

Moderately Similar
1 trials

Shared therapeutic areas:

Neoplasms, Germ Cell and Embryonal
Similarity Score30%

Michal Mego, prof

National Cancer Institute (NCI)

Moderately Similar
1 trials

Shared therapeutic areas:

Neoplasms, Germ Cell and Embryonal
Similarity Score30%

Diogo Bastos, MD

Instituto do Cancer do Estado de São Paulo

Moderately Similar
1 trials

Shared therapeutic areas:

Neoplasms, Germ Cell and Embryonal
Similarity Score30%

Jonathan Dewey, MD

Servier Pharmaceuticals, LLC

Moderately Similar
1 trials

Shared therapeutic areas:

Neoplasms, Germ Cell and Embryonal
Similarity Score30%

David S Schrump, M.D.

National Cancer Institute (NCI)

Moderately Similar
21 trials

Shared therapeutic areas:

Neoplasms, Germ Cell and Embryonal
Similarity Score30%

Nathalie Billon

Sanofi

Moderately Similar
5 trials

Shared therapeutic areas:

Neoplasms, Germ Cell and Embryonal
Similarity Score30%

Gregory Friedman, MD

M.D. Anderson Cancer Center

Moderately Similar
2 trials

Shared therapeutic areas:

Neoplasms, Germ Cell and Embryonal
Similarity Score30%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT02533765Phase 2PrincipalInvestigator

Olaparib as Salvage Treatment for Cisplatin-resistant Germ Cell Tumor

Neoplasms, Germ Cell and Embryonal
Completed

All 1 trials loaded